• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

B 系急性淋巴细胞白血病中 CD24 抗原表达缺失与原发性克隆形成性母细胞的内在辐射抗性相关。

Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.

作者信息

Uckun F M, Song C W

机构信息

Department of Therapeutic Radiology-Radiation Oncology, University of Minnesota Health Sciences Center, Minneapolis.

出版信息

Blood. 1993 Mar 1;81(5):1323-32.

PMID:8443393
Abstract

The radiation sensitivity of primary clonogenic blasts from 27 children with immunologically classified CD2-CD5-CD7-CD19+slg- B-lineage acute lymphoblastic leukemia (ALL) was analyzed using leukemic progenitor cell (LPC) colony assays. Radiation survival curves of primary clonogenic blasts (ie, LPC) were constructed for each patient using computer programs for the single-hit multitarget as well as the linear quadratic models of cell survival. The D0 values ranged from 49 to 891 cGy (median, 239 cGy; mean +/- SE, 307 +/- 44 cGy) and the alpha values ranged from 0.000 to 2.047 Gy-1 (median, 0.156 Gy-1; mean +/- SE, 0.284 +/- 0.078 Gy-1). Patients were divided into groups according to sex, age, white blood cell count (WBC) at diagnosis, plating efficiency of primary bone marrow blasts, and immunophenotype. Patient sex, age, WBC at diagnosis, or in vitro plating efficiency was not associated with radiation resistance. Notably, freshly isolated primary clonogenic blasts from patients with a CD19+CD24-CD34+ composite immunophenotype (stage I B-cell precursor [BCP]) had 2.2-fold higher D0 values (P = .005) and 3.4-fold lower alpha values (P = .05) than those from patients with a CD19+CD24+CD34+ (stage II BCP) or CD19+CD24+CD34- (stage III BCP) immunophenotype. The relative values for CD24- primary clonogenic blasts signify greater intrinsic radiation resistance. Furthermore, the CD19+CD24-CD34+ immunophenotype had a larger radiation resistant fraction. Whereas only 60% of CD19+CD24+CD34+ and 33% of CD19+CD24+CD34- cases had clonogenic blasts with alpha < or = 0.2, 100% of CD19+CD24-CD34+ cases had clonogenic blasts with alpha < or = 0.2. Furthermore, clonogenic blasts from established CD19+CD24- B-lineage ALL cell lines were significantly more radiation resistant than CD19+CD24+ B-lineage ALL cell lines. Notably, radiation doses sufficient to induce apoptosis of CD24- B-lineage ALL cells were higher than those capable of inducing apoptosis in CD24+ B-lineage ALL cells. Thus, the lack of CD24 surface antigen expression in B-lineage ALL is associated with intrinsic radiation resistance at the level of primary clonogenic blasts.

摘要

采用白血病祖细胞(LPC)集落分析法,分析了27例免疫分型为CD2-CD5-CD7-CD19+slg- B系急性淋巴细胞白血病(ALL)患儿的原代克隆形成性母细胞的辐射敏感性。使用单击中靶及细胞存活的线性二次模型的计算机程序,为每位患者构建原代克隆形成性母细胞(即LPC)的辐射存活曲线。D0值范围为49至891 cGy(中位数为239 cGy;平均值±标准误为307±44 cGy),α值范围为0.000至2.047 Gy-1(中位数为0.156 Gy-1;平均值±标准误为0.284±0.078 Gy-1)。根据性别、年龄、诊断时白细胞计数(WBC)、原代骨髓母细胞的接种效率及免疫表型将患者分组。患者的性别、年龄、诊断时的WBC或体外接种效率与辐射抗性均无关。值得注意的是,具有CD19+CD24-CD34+复合免疫表型(I期B细胞前体[BCP])患者的新鲜分离的原代克隆形成性母细胞的D0值比具有CD19+CD24+CD34+(II期BCP)或CD19+CD24+CD34-(III期BCP)免疫表型患者的高2.2倍(P = 0.005),α值低3.4倍(P = 0.05)。CD24-原代克隆形成性母细胞的相对值表明其具有更高的内在辐射抗性。此外,CD19+CD24-CD34+免疫表型具有更大的抗辐射部分。仅60%的CD19+CD24+CD34+和33%的CD19+CD24+CD34-病例的克隆形成性母细胞α≤0.2,而100%的CD19+CD24-CD34+病例的克隆形成性母细胞α≤0.2。此外,已建立的CD19+CD24- B系ALL细胞系的克隆形成性母细胞比CD19+CD24+ B系ALL细胞系对辐射的抗性明显更强。值得注意的是,足以诱导CD24- B系ALL细胞凋亡的辐射剂量高于能够诱导CD24+ B系ALL细胞凋亡的剂量。因此,B系ALL中CD24表面抗原表达的缺失与原代克隆形成性母细胞水平的内在辐射抗性相关。

相似文献

1
Lack of CD24 antigen expression in B-lineage acute lymphoblastic leukemia is associated with intrinsic radiation resistance of primary clonogenic blasts.B 系急性淋巴细胞白血病中 CD24 抗原表达缺失与原发性克隆形成性母细胞的内在辐射抗性相关。
Blood. 1993 Mar 1;81(5):1323-32.
2
Radiation resistance of primary clonogenic blasts from children with acute lymphoblastic leukemia.急性淋巴细胞白血病患儿原代克隆形成性母细胞的辐射抗性。
Int J Radiat Oncol Biol Phys. 1993 Nov 15;27(4):899-906. doi: 10.1016/0360-3016(93)90466-9.
3
Intrinsic radiation resistance of primary clonogenic blasts from children with newly diagnosed B-cell precursor acute lymphoblastic leukemia.新诊断的B细胞前体急性淋巴细胞白血病患儿原代克隆形成母细胞的内在辐射抗性。
J Clin Invest. 1993 Mar;91(3):1044-51. doi: 10.1172/JCI116261.
4
In vitro and in vivo radiation resistance associated with CD3 surface antigen expression in T-lineage acute lymphoblastic leukemia.T 系急性淋巴细胞白血病中与 CD3 表面抗原表达相关的体外和体内辐射抗性
Blood. 1991 Dec 1;78(11):2945-55.
5
Immunophenotype predicts radiation resistance in T-lineage acute lymphoblastic leukemia and T-lineage non-Hodgkin's lymphoma.免疫表型可预测T系急性淋巴细胞白血病和T系非霍奇金淋巴瘤的放射抗性。
Int J Radiat Oncol Biol Phys. 1992;24(4):705-12. doi: 10.1016/0360-3016(92)90718-w.
6
Radiation damage repair capacity of primary clonogenic blasts in acute lymphoblastic leukemia.急性淋巴细胞白血病中原代克隆形成性母细胞的辐射损伤修复能力。
Cancer Res. 1993 Mar 15;53(6):1431-6.
7
Engagement of the CD19 receptor on human B-lineage leukemia cells activates LCK tyrosine kinase and facilitates radiation-induced apoptosis.人B系白血病细胞上CD19受体的激活可激活LCK酪氨酸激酶并促进辐射诱导的细胞凋亡。
Radiat Res. 1993 Dec;136(3):313-9.
8
Autologous bone marrow transplantation in high-risk remission B-lineage acute lymphoblastic leukemia using a cocktail of three monoclonal antibodies (BA-1/CD24, BA-2/CD9, and BA-3/CD10) plus complement and 4-hydroperoxycyclophosphamide for ex vivo bone marrow purging.使用三种单克隆抗体(BA-1/CD24、BA-2/CD9和BA-3/CD10)加补体以及4-氢过氧环磷酰胺进行体外骨髓净化,用于高危缓解期B系急性淋巴细胞白血病的自体骨髓移植。
Blood. 1992 Feb 15;79(4):1094-104.
9
Prognostic significance of the CD10+CD19+CD34+ B-progenitor immunophenotype in children with acute lymphoblastic leukemia: a report from the Children's Cancer Group.CD10+CD19+CD34+B祖细胞免疫表型在儿童急性淋巴细胞白血病中的预后意义:儿童癌症研究组报告
Leuk Lymphoma. 1997 Nov;27(5-6):445-57. doi: 10.3109/10428199709058311.
10
Sensitivity of primary clonogenic blasts from acute lymphoblastic leukemia patients to an activated cyclophosphamide, viz., mafosfamide.急性淋巴细胞白血病患者原代克隆形成性母细胞对活化环磷酰胺即马磷酰胺的敏感性。
Leuk Lymphoma. 1994 May;13(5-6):417-28. doi: 10.3109/10428199409049631.

引用本文的文献

1
Roles of the phagocytosis checkpoint in radiotherapy.吞噬作用检查点在放射治疗中的作用。
Cell Death Dis. 2025 Aug 20;16(1):630. doi: 10.1038/s41419-025-07921-5.
2
Targeting myeloid cells for hematological malignancies: the present and future.针对血液系统恶性肿瘤的髓系细胞:现状与未来。
Biomark Res. 2025 Apr 10;13(1):59. doi: 10.1186/s40364-025-00775-1.
3
CD24 as a Potential Therapeutic Target in Patients with B-Cell Leukemia and Lymphoma: Current Insights.CD24作为B细胞白血病和淋巴瘤患者的潜在治疗靶点:当前见解
Onco Targets Ther. 2022 Nov 18;15:1391-1402. doi: 10.2147/OTT.S366625. eCollection 2022.
4
CD24: A Novel Target for Cancer Immunotherapy.CD24:癌症免疫疗法的新靶点。
J Pers Med. 2022 Jul 28;12(8):1235. doi: 10.3390/jpm12081235.
5
Commonly Assessed Markers in Childhood BCP-ALL Diagnostic Panels and Their Association with Genetic Aberrations and Outcome Prediction.儿童 BCP-ALL 诊断面板中常见评估标志物及其与遗传异常和预后预测的关系。
Genes (Basel). 2022 Jul 31;13(8):1374. doi: 10.3390/genes13081374.
6
The Impact of Exosomes/Microvesicles Derived from Myeloid Dendritic Cells Cultured in the Presence of Calcitriol and Tacalcitol on Acute B-Cell Precursor Cell Lines with Fusion Gene.在骨化三醇和他卡西醇存在的情况下培养的髓样树突状细胞衍生的外泌体/微囊泡对具有融合基因的急性B细胞前体细胞系的影响
J Clin Med. 2022 Apr 15;11(8):2224. doi: 10.3390/jcm11082224.
7
Feasibly of CD24/CD11b as a Screening Test for Hematological Malignancies.CD24/CD11b作为血液系统恶性肿瘤筛查试验的可行性
J Pers Med. 2021 Jul 27;11(8):724. doi: 10.3390/jpm11080724.
8
Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies.基质微环境的共性凸显了基质细胞蛋白SPARC对B细胞发育和淋巴系统恶性肿瘤的作用。
Oncoimmunology. 2014 Jun 5;3:e28989. doi: 10.4161/onci.28989. eCollection 2014.
9
Novel Bruton's tyrosine kinase inhibitors currently in development.目前正在研发的新型布鲁顿酪氨酸激酶抑制剂。
Onco Targets Ther. 2013;6:161-76. doi: 10.2147/OTT.S33732. Epub 2013 Mar 6.
10
CD24 expression is an independent prognostic marker in cholangiocarcinoma.CD24表达是胆管癌的一个独立预后标志物。
J Gastrointest Surg. 2007 Apr;11(4):445-51. doi: 10.1007/s11605-007-0091-5.